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Significance statement
The remarkable power of enzymes as catalysts is derived from the precise spatial positioning of amino acids as a result of a polypeptide folding into its native, active fold. Protein engineers have a wide arsenal of tools available to alter the properties of enzymes but, until recently, have been limited to replacement of amino acids with one of the other naturally occurring proteogenic amino acids. Here we describe a protein engineering approach to introduce a non-canonical amino acid that results in altered substrate specificity of an aldolase to produce a novel activity that cannot be achieved by simple substitution with any of the canonical amino acids.
\body Introduction
Enzymes are phenomenally powerful catalysts that increase reaction rates by up to 10 18 -fold (1, 2) , and a new era of enzyme applications has been opened by the advancement of protein engineering and directed evolution to provide new, or improved, enzymes for industrial biocatalysis. Enzymes are attractive catalysts because they are highly selective, carrying out regio-, chemo-and stereo-selective reactions that are challenging for conventional chemistry. Moreover, enzymes are efficient catalysts, function under mild conditions with relatively non-toxic reagents, and enable the production of relatively pure products, minimising waste generation. In recent years, there has been much success in engineering enzymes for desired reactions (3-5) using methods such as rational protein engineering (6) (7) (8) , directed evolution (9) (10) (11) and, most recently, computational enzyme design (12) (13) (14) (15) .
Enzymes found in Nature achieve catalysis using active sites generally composed of only 20 canonical amino acids, which are encoded at the genetic level, plus the rarer selenocysteine and 1-pyrrolysine.
However, many enzymes also rely on one or more of 27 small organic cofactor molecules and/or 13 metal ions for their function (16) . In addition, in some cases, Nature has exploited non-canonical amino acids (Nca) in catalysis to extend its catalytic repertoire: for example, the quinones TPQ, LTQ, TTQ and CTQ respectively in amine oxidase, lysyl oxidase, methylamine dehydrogenase and quinohemoprotein amine dehydrogenase (17) ; a pyruvoyl group in some histidine, arginine, aspartate and S-adenosylmethionine decarboxylases (18) ; formyl glycine residues in Type I sulfatases (19) ; and 4-methylideneimidazole-5-one (MIO) in ammonia lyases and 2,3-aminomutases (20) . These Ncas are vital for catalysis and arise through post-translational modifications of the polypeptide chain (21, 22) allowing access to chemistries not otherwise provided by the 20 proteogenic amino acids.
Technologies for the protein engineer to incorporate Ncas into proteins at specifically chosen sites, either by genetic means (23) (24) (25) or by chemical modification (26, 27) have recently been developed.
These approaches are powerful, since, unlike traditional protein engineering with the 20 canonical amino acids, protein engineering with Ncas has almost unlimited novel side-chain structures and chemistries from which to choose. This ability has been exploited to increase the stability of leucinezipper peptides by replacing leucines with trifluoroleucine (Tfl) while maintaining the DNA-binding functions (28) . Moreover, by screening random libraries with a sense codon global substitution method to replace Leu with Tfl, a mutant Tfl-containing enzyme with enhanced thermal stability (29) and a mutant Tfl-containing GFP with increased fluorescence intensity (30) were obtained.
Incorporation of Ncas has also been used to generate a novel metalloenzyme by the in vivo incorporation of metal-binding Ncas into an active site (31) . Furthermore, the efficiency of phosphotriesterase with the substrate paraoxon was improved by replacement of Tyr309 with the Nca L-(7-hydroxycoumarin-4-yl) ethyl glycine (32), generating a 10-fold improvement of an already highly efficient enzyme.
A particular challenge is the engineering of new enzymes for carboncarbon bond formation, for example aldolases (33) , since these can increase molecular complexity and control the formation of new stereocentres. We have taken the opportunity to incorporate Ncas into an aldolase to search for new activities that are dependent on the distinctive properties of the introduced Nca. The genetic incorporation of Ncas encodes the Nca as an amber STOP codon which is read by an orthogonal tRNA / amino acyl tRNA synthetase (tRNAS) pair to introduce directly the Nca in vivo (25) . However, this method becomes extremely laborious if the effect of many different Ncas is to be investigated, as new orthogonal tRNA/tRNAS pairs must be evolved for each Nca. We have instead used chemical mutagenesis to incorporate a diverse range of Ncas throughout the active site of an aldolase, prior to screening these variants for activity with new substrates. We demonstrate that using this approach we can alter the substrate specificity of the enzyme, and achieve levels of activity towards a new substrate that are otherwise unattainable by mutagenesis to any of the canonical amino acids.
Results

Production of modified enzymes
N-Acetyl neuraminic acid lyase (NAL) catalyses the aldol reaction of N-acetyl-D-mannosamine and pyruvate to form N-acetylneuraminic acid (Fig. 1, Panel A) . The substrate specificity and stereochemistry of this enzyme is highly malleable through protein engineering and directed evolution (34, 35) , and we have shown that an enzyme bearing the Nca -thialysine (2-aminoethyl cysteine) in place of the catalytic Lys-165 retains activity (36) . Here we have explored the effect of introducing Ncas throughout the active site on the reaction catalysed.
Twelve residues in the active site of S. aureus NAL were selected as positions for Nca incorporation (Fig. 2) . The chemical modification procedure to introduce the Nca relies on the conversion of a cysteine into dehydroalanine by a bis-alkylation / elimination sequence (27, 36) , followed by Michael addition of a thiol to introduce the new Nca side-chain. The S. aureus NAL naturally contains no cysteines making it an ideal target protein for chemical introduction of Ncas (36) . The residues chosen for modification were picked based on their proximity to the aldehyde substrate binding pocket in the previously solved structure of an E.coli NAL variant in complex with 4-epi N-acetylneuraminic acid (pdb 4BWL) (37) (Fig. 3) . The equivalent positions in the S. aureus NAL based on structural alignment were then mutated into cysteine residues by site-directed mutagenesis, and expressed and purified as previously described (36) . The Ncas were then incorporated by first converting the cysteine to dehydroalanine (Dha) using 2,5-dibromohexan-1,6-diamide and then Michael addition with 13 different thiols resulting in installation of 13 different Ncas at each of the 12 positions (27) (Fig. 2) . The thiols chosen emcompass a wide variety of non-canonical side chains, some mimicking elongated versions of canonical amino acids and some incorporating functionalities that are either absent or uncommon in the canonical amino acids. Incorporation was carried out on a small (2.5 mg) scale under denaturing conditions to ensure the cysteine residue was accessible for modification before the protein was refolded. This procedure was previously shown to generate active, modified, refolded
Screening and activity
NAL is highly specific for its ketone donor (pyruvate), while accepting a range of aldehyde acceptors (38, 39) . However the wild-type enzyme has a strong preference for longer aldehydes (38) (39) (40) : C4 aldehydes are generally poorly accepted (38) and C3 aldehydes are not substrates (39) . The differently modified enzymes at each of the positions in the polypeptide chain were screened in 96-well plates for altered activity and specificity in condensing pyruvate with a range of aldehyde substrates with different lengths (C4 to C6), stereochemistry and functional groups (Fig. 2 ). Enzyme activity was assessed using a variation of the established thiobarbituric acid (TBA) assay (41) . Aldol reaction of pyruvate with the aldehydes in Table 1 To confirm that Phe190Dpc NAL catalyses the aldol reaction of pyruvate with erythrose to generate 3-deoxy-2-heptulosonic acid (DHA) (Fig. 1, Panel B) , a large scale reaction was incubated for 48 hours with Phe190Dpc NAL, and the resulting diastereomeric mixture of product (DHA) was purified by anion exchange chromatography. The 500 MHz 1 H, COSY and TOCSY NMR spectra (Fig. S3 ) were in agreement with reported data (42) for the expected product (DHA), and showed that a ~75:25 mixture of C4-configured products had been formed (Table S1 ).
Characterisation of Phe190Dpc NAL
To evaluate fully the switch in substrate specificity caused by the introduction of the Dpc side chain at position 190, full kinetic characterisation of the reactions involving both ManNAc and erythrose was carried out. A large quantity (~ 50 mg) of Phe190Dpc NAL was produced and was subjected to size exclusion chromatography to remove any incorrectly folded protein produced during the refolding stage of the modification process. Mass spectrometry (Fig. S1) showed that the modified enzyme had the expected molecular mass for Phe190Dpc NAL. Steady-state kinetic parameters (kcat(app) and Km(app) for aldehyde) were determined for wild-type and Phe190Dpc NAL using the TBA assay (41) ( (C4) aldehydes with high levels of catalytic activity can be generated.
Saturation mutagenesis of residue 190
To compare the activity achieved by insertion of Dpc at residue 190 of NAL, with that achievable by any of the 20 canonical amino acids, a saturation library at position 190 was produced. All 19 variants were produced by site-directed mutagenesis, expressed and purified (36) . Kinetic parameters were then determined for the saturation library in the same way as for the wild-type and Phe190Dpc
enzymes. Fig. 5 shows that varying the canonical amino acid at position 190 of the S. aureus NAL resulted in small increases in the activity of the enzyme towards the reaction of pyruvate with erythrose. In contrast, insertion of Dpc at position 190 produced an enzyme that was about 5-times more active with erythrose (in terms of both kcat(app) and kcat/Km(app)) than the best canonical amino acid (Glu) (Fig. 5B) . These data clearly highlight the benefits of exploring a widened chemical space with regards to broadening enzyme substrate specificity.
Structural characterisation
It was interesting that the slight changes in enzyme specificity brought about by site-directed mutagenesis to introduce other canonical amino acids at position 190 in S. aureus NAL were mainly derived from changes in the apparent Km for the aldehyde substrate (Fig. 5B) . In contrast, the specificity change brought about by the introduction of the non-canonical Dpc side-chain was largely generated by changes in kcat(app) rather than Km(app) ( Table 1) . To investigate further the specificity change, we determined the structure of the Phe190Dpc NAL in complex with pyruvate (PDB 5LKY). that the Michael addition of racemic 2,3-dihydroxy propanethiol to the unfolded protein was stereocontrolled; rather, we hypothesise, as previously (36) , that only one stereoisomer of the modified protein can re-fold correctly and is recovered after gel filtration.
The Dpc190 side-chain is positioned between Glu192 and Asp141 and points into the active site where it extends further (average 0.8 Å ± 0.1 Å from all four subunits) into the active site than the corresponding phenylalanine in the wild-type structure. The non-canonical side chain exhibits a high degree of flexibility in the active site, adopting different conformations in all four subunits (Fig. S5) . In subunit A, the Dpc side chain was modelled in two different conformations which resulted from a C -C . In both subunits A and B, the hydroxyl groups of the Dpc side chain make hydrogen bond interactions to the side chains of Glu192 and Asp141 (Fig 6B) . Another notable difference between wild-type and Phe190Dpc NAL was at the region 167-169. In the Phe190Dpc structure, the removal of the bulky hydrophobic phenylalanine allows the backbone chain containing residues Thr167, Ala168 and Pro169 to move closer to the catalytic Lys165 in the active site (Fig S6) .
This results in the C of Thr167 in the Phe190Dpc structure being displaced on average 1.0 Å ± 0.1 Å and adopting a different rotamer when compared to the wild-type structure (Fig. 6A & B, Fig S6) .
Previous QMMM modelling of the reaction mechanism of the E. coli NAL (37) has suggested that Thr167 binds to the aldehyde oxygen atom and helps to stabilise the transition state of the reaction.
Unfortunately, we were unable to determine the crystal structure of the modified Phe190Dpc NAL with the reaction product DHA bound and so we turned to molecular modelling to try to elucidate the structural basis for the change of specificity.
Computational energy minimisation experiments were carried out on the Schiff bases formed between the product DHA and both the wild-type and Phe190Dpc NALs. The models revealed that, as expected, the DHA, being shorter than the natural substrate Neu5Ac, does not make the same interactions with Glu-192 of the enzyme (37) (Fig S8) . Because of our finding that both 4R-and 4S-DHA were formed by Phe190Dpc NAL, both stereoisomers were modelled into the active sites. The minimisations revealed that C1-C3 of either C4 diastereoisomer of DHA were bound in the same way in both the wild-type and Phe190Dpc models. However there were significantly different interactions at the other end (C4-C7) of the product. Tyr252 lies slightly further from the product in both 4(R) and 4(S) DHA-Phe190Dpc NAL models, meaning that it can no longer hydrogen bond with the product C5 in the wild-type model. This brings the Dpc 3.0 Å closer to the product than the phenylalanine in the wild-type model (Fig S7) . Thus, molecular modelling suggests that the newly introduced Dpc side chain at residue 190 alters the substrate specificity not by direct interaction with DHA, but rather by altering the conformation and interaction network in the active site resulting in better transition state stabilisation. This observation is entirely consistent with the kinetic data ( Table 2) where the switch in substrate specificity measured by kcat/Km(app) is almost entirely due to alterations in kcat(app) rather than in Km(app).
Discussion
Aldolases are an important class of biocatalysts which are finding increasing uses in the synthesis of complex compounds (33) . They are particularly useful in that they can create two stereochemical centres during their reaction (34, (44) (45) (46) and that the reactions can be carried out in aqueous solvent without the use of protecting groups. However, the substrate specificity of natural aldolases often has to be engineered in order to produce enzymes with the required substrate specificity (33, 47) . Rational protein engineering and directed evolution have been successful in addressing this problem, but the protein engineer is nonetheless fundamentally limited to alterations of amino acids to any of the other 19 canonical amino acids. The recent invention of methods to allow the incorporation of non-canonical amino acids into proteins, either by genetic incorporation or by chemical modification, has opened the way to explore wider areas of structureactivity space. Chemical modification methods have particular value since many different Ncas may be incorporated easily, enabling the function of the resulting variants to be explored. Here, we have shown that by utilising a non-canonical amino acid, it is possible not only to alter the aldehyde acceptor of the natural enzyme, but also to increase the activity with the altered substrate to rates that are unattainable with only the 20 proteogenic amino acids.
By modifying position 190 of the S. aureus NAL to a 2,3-dihydroxypropyl cysteine, the enzyme activity for the reaction of erythrose and pyruvate to form DHA (Fig. 1 ) has been significantly increased. A phosphorylated form of DHA (7-phospho DHA) is an important intermediate in the shikimate pathway for the biosynthesis of aromatic amino acids (48) and there has been much interest in the preparation of DHA, and other 3-deoxy-2-ulosonic acids, due to their potential as starter units for complex oligosaccharide syntheses (42, (48) (49) (50) . Our structural studies showed that the non-canonical amino acid is perfectly shaped and functionalised to interpose between Asp141 and Glu192; reducing the active site volume causing a remodelling of the active site to stabilise better the transition state of the DHA-producing reaction. In stark contrast, none of the canonical amino acids possess the required molecular characteristics in a single residue, demonstrating that Ncas can extend the ambitions of the protein engineer. Based on the data presented here, we envisage that advances in computational (12, 13) and (semi-)rational methods (6) 
Materials and Methods
Further details may be found in Supporting Text.
Chemical modification using various different thiols
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Screening using the thiobarbituric acid (TBA) assay
Modified enzymes were screened for aldol reaction activity with pyruvate and a variety of aldehydes.
Reactions in 96 deep well plates contained pyruvate (100 µL, final concentration 80 mM), aldehyde (100 µL, final concentration 8 mM) and modified enzyme (50 µL of 1.0 mg/mL (1.5 nmol)). Reactions were incubated for 16 hours at room temperature and activity was assessed by the TBA assay. 
Kinetic assays
Kinetic parameters were determined using the TBA assay. 100 µL reactions contained erythrose (0.8- 
Protein crystallisation, data collection and refinement
Crystallisation conditions were as previously described (36, 53) . Diffraction data for the Phe190Dpc structure were collected from a single crystal at the Diamond Light Source macromolecular crystallography beam line I04-1 flash cooled to 100 K. Data processing and refinement were carried out as previously described (36) . Coordinates and restraint library files for the 2, 3-dihydroxypropyl cysteine side chain (HET code P9S) were generated using the PRODRG (54) server and manually edited.
The models were validated using the PDB validation server. Atomic coordinates and structure factors have been deposited into the Protein data Bank with the accession code 5LKY (Table S2 ).
Computational energy minimisations
Computational energy minimisations were carried out using the Schrodinger Small Molecule Discovery Suite (Schrödinger Release 2015-1: Maestro, Schrödinger, LLC, New York). Maestro was used to model the Schiff bases between the product DHA and the catalytic lysine of subunit B of the wild-type or Phe190Dpc NAL. Energy minimisation of the products formed was carried out using Macromodel with the OPLS_2005 force field (55) with water as solvent. All amino acid side chains within 6 Å of the product were allowed to minimise, as well as the product itself. Cysteine residues were introduced individually into S. aureus NAL by site-directed mutagenesis at each position shown. After conversion into dehydroalanine, each position was modified separately with the thirteen thiols shown. The resulting enzymes were screened using the thiobarbituric acid assay for activity in condensing pyruvate with the aldehydes shown. The crystal structure of the Y137A mutant of E. coli NAL in complex with N-acetylneuraminic acid (Neu5Ac) (PDB 4BWL) (35) was used to select sites at which to incorporate Ncas. Residues were selected based on proximity (<8 Å) to the position of the Neu5Ac substrate (dark purple), and were separately mutated to cysteine residues. Residues at these positions are conserved between the E. coli and S. aureus enzymes except for the following conservative changes (E. coli residue first): D170N, Y172F, Y190F I247L, V251I and F252Y. Overnight reactions of enzyme (0.2 mg; 5.8 nmol) with aldehyde (8 mM) and pyruvate (80 mM) were assayed using the TBA assay and the absorbance read at 550 nm. The difference in A550 between the reaction with the modified enzyme and the wild-type enzyme were calculated. Values below zero (modified enzyme is less active than wild-type) are blue with the intensity proportional to the activity difference. Values greater than zero (modified enzyme is more active than wild-type) are similarly coloured in pink. Modified enzymes are ranked by order of activity with pyruvate and erythrose. Activity of NAL variants bearing the 20 canonical amino acids at position 190 was measured using the TBA assay and compared with NAL bearing the Nca Dpc at position 190. Initial reaction rates were determined using the TBA assay under conditions where the time course of product formation is linear (Fig. S4) 
